Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
, rheumatoid arthritis) (264)
No Rebound Weight Gain Within the first 1-2 weeks after stopping SMG treatment at Week 35 across all treatment groups, SMG-monotherapy-treated animals regained all lost weight and tracked back to saline-treated animals
Tully, D
US$ 25.19
US$ 26.12
US$ 24.42
